The senior investigator at the National Institute on Aging talked about targeting pathologies in neurodegenerative diseases at the 2023 AAN Annual Meeting. [WATCH TIME: 6 minutes]
Madhav R. Thambisetty, MD, PhD
Advertisement
Senior investigator at the National Institute on Aging and adjunct professor of neurology at the Johns Hopkins University School of Medicine.
Articles by Madhav R. Thambisetty, MD, PhD
Advertisement
Latest Updated Articles
Development of Neuropathology Targeted Treatments in Alzheimer Disease: Madhav R. Thambisetty, MD, PhDPublished: April 24th 2023 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
New Phase 3 Study to Evaluate Remibrutinib in Generalized Myasthenia Gravis Treatment
2
Early-Stage Study to Test CD19 CAR T-Cell Therapy YTB323 in Myasthenia Gravis
3
Surveying Global Nursing Needs for Patients With Generalized Myasthenia Gravis: Amy Perrin Ross, APN, MSN, CNRN, MSCN
4
Jessica Neil, PA, on the Evolution of Patients With Headache
5
